BioCardia, Inc. (BCDA)
NASDAQ: BCDA · Real-Time Price · USD
1.180
-0.050 (-4.07%)
At close: Dec 30, 2025, 4:00 PM EST
1.190
+0.010 (0.85%)
After-hours: Dec 30, 2025, 5:47 PM EST
BioCardia Employees
As of December 31, 2024, BioCardia had 20 total employees, including 16 full-time and 4 part-time employees. The number of employees did not change compared to the previous year.
Employees
20
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$427,000
Market Cap
12.52M
Employees Chart
Employees History
| Date | Employees | Change | Growth |
|---|---|---|---|
| Dec 31, 2024 | 20 | 0 | - |
| Dec 31, 2023 | 20 | -16 | -44.44% |
| Dec 31, 2022 | 36 | 1 | 2.86% |
| Dec 31, 2021 | 35 | 6 | 20.69% |
| Dec 31, 2020 | 29 | 5 | 20.83% |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2014 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Related Stocks
| Company Name | Employees |
|---|---|
| UnitedHealth Group | 400,000 |
| Johnson & Johnson | 138,100 |
| Thermo Fisher Scientific | 125,000 |
| Abbott Laboratories | 114,000 |
| AstraZeneca | 92,900 |
| Novo Nordisk | 77,349 |
| Novartis AG | 75,883 |
| Merck & Co. | 75,000 |
BCDA News
- 14 days ago - BioCardia Cell Therapy for Ischemic Heart Failure to Progress to Formal Clinical Consultation with Japan PMDA - GlobeNewsWire
- 4 weeks ago - BioCardia to Present at December 2025 CSI Focus Devices in Heart Failure Congress - GlobeNewsWire
- 5 weeks ago - BioCardia Strengthens Leadership Team with The Addition of Farhan Shahab as Vice President of Quality - GlobeNewsWire
- 6 weeks ago - BioCardia, Inc. (BCDA) Q3 2025 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - BioCardia Reports Third Quarter 2025 Business Highlights and Financial Results - GlobeNewsWire
- 7 weeks ago - BioCardia to Host Q3 2025 Corporate Update and Financial Results Conference Call on November 12, 2025 - GlobeNewsWire
- 3 months ago - BioCardia Regains Compliance with Nasdaq Listing Requirements - GlobeNewsWire
- 3 months ago - BioCardia Announces Pricing of Up To $12 Million Public Offering - GlobeNewsWire